StockData

Incannex Healthcare vs NeOnc Technologies

IXHL and NTHI side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How IXHL and NTHI compare

NeOnc Technologies is the larger company, worth 5.1 times as much as Incannex Healthcare ($112M against $21.8M).

Incannex Healthcare scores higher on the StockData Score (7 against 0 for NeOnc Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricIXHLNTHI
Size and price
Market cap$21.8M$112M
Share price$1.74$4.33
Change, 1 year−83.5%−52.3%
Beta (5Y)2.402.81
Employees125
StockData Score
Total score7 (better)0
Valuation score1 (better)0
Growth score00
Performance score1 (better)0
Health score5 (better)0
Dividend score00
Valuation
P/B0.3×–
FCF yield−14.6%–
Profitability
Return on equity−20.7%–
Return on invested capital−1945%–
Financial health
Debt / equity0.00–
Interest coverage–−15.7×
Current ratio67.79 (better)0.38
Altman Z-score−0.22 (better)−34.30
Piotroski F-score4 (better)2
Dividends and buybacks
Buyback yield−42.2%–
Shareholder yield−42.2%0.00% (better)
Ownership
Held by institutions3.6%12.2%
Held by insiders–60.1%
Insider net buying, 12 months–$2.0M
Short interest, % of float–8.9%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.